Compounds > 8-hydroxy-2-(di-n-propylamino)tetralin
Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Apnea, Central

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Apnea, Central in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stettner, GM1
Zanella, S1
Hilaire, G1
Dutschmann, M1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Apnea, Central

ArticleYear
8-OH-DPAT suppresses spontaneous central apneas in the C57BL/6J mouse strain.
    Respiratory physiology & neurobiology, 2008, Mar-20, Volume: 161, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Mice; Mice, Inbred C57BL; Plethysmography, Whole Bo

2008